Cargando…

Clinicopathological features and prognostic implications of ASCL1 expression in surgically resected small cell lung cancer

BACKGROUND: Small cell lung cancer (SCLC) is one of the most aggressive lung cancers. Treatment of SCLC has remained unchanged during the past decades. Preclinical studies have revealed ASCL1 as a transcription regulator in the neuroendocrine (NE) differentiation and carcinogenesis of SCLC. However,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Jiacong, Liu, Li, Guo, Yiying, Zhang, Jinyao, Wang, Xin, Dong, Jiyan, Xing, Puyuan, Ying, Jianming, Yang, Lin, Li, Junling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779202/ https://www.ncbi.nlm.nih.gov/pubmed/33191657 http://dx.doi.org/10.1111/1759-7714.13705

Ejemplares similares

ASCL1 and DLL3 expressions and their clinicopathological implications in surgically resected pure small cell lung cancer: A study of 247 cases from the National Cancer Center of China
por: Hu, Chunfang, et al.
Publicado: (2021)

Comparative study of clinicopathological characteristics and prognosis between combined and pure small cell lung cancer (SCLC) after surgical resection
por: Guo, Yiying, et al.
Publicado: (2020)

Prognostic significance of YAP1 expression and its association with neuroendocrine markers in resected pulmonary large cell neuroendocrine carcinoma (LCNEC)
por: Sun, Xujie, et al.
Publicado: (2022)

Clinical significance of ALDH1A1 expression and its association with E-cadherin and N-cadherin in resected large cell neuroendocrine carcinoma
por: Zhang, Jinyao, et al.
Publicado: (2022)

Heterogeneity in intracranial relapses after complete resection of lung adenocarcinoma: Distinct features of brain‐only relapse versus synchronous extracranial relapse
por: Xu, Fei, et al.
Publicado: (2023)

Clinicopathological and prognostic implications of ALK rearrangement in patients with completely surgically resected lung adenocarcinoma
por: Zhang, Huan, et al.
Publicado: (2021)

TERT Mutations in Non–Small Cell Lung Cancer: Clinicopathologic Features and Prognostic Implications
por: Yang, Liu, et al.
Publicado: (2023)

Acquired resistance to osimertinib in patients with non-small-cell lung cancer: mechanisms and clinical outcomes
por: Mu, Yuxin, et al.
Publicado: (2020)

Clinicopathologic features and prognostic implications of NOK/STYK1 protein expression in non-small cell lung cancer
por: Chen, Peng, et al.
Publicado: (2014)

Clinicopathological Features and Prognostic Implication of Gastric Carcinoma with Lymphoid Stroma
por: Pyo, Jung-Soo, et al.
Publicado: (2020)

Adjuvant chemotherapy in patients with recurrence after completely resected stage IB lung adenocarcinoma: Propensity‐matched analysis in a cohort of 147 recurrences
por: Xu, Fei, et al.
Publicado: (2022)

The N terminus of Ascl1 underlies differing proneural activity of mouse and Xenopus Ascl1 proteins
por: Hardwick, Laura J.A., et al.
Publicado: (2018)

Assessing Epstein–Barr virus in gastric cancer: clinicopathological features and prognostic implications
por: Li, Guanghua, et al.
Publicado: (2023)

Clinicopathological and Prognostic Value of Survivin Expression in Surgically Resected Pancreatic Ductal Adenocarcinoma
por: Vay, Christian, et al.
Publicado: (2022)

Clinicopathologic Features and Prognostic Implications of Golgi Phosphoprotein 3 in Non-small Cell Lung Cancer: A Meta-analysis
por: Shi, Wenhua, et al.
Publicado: (2019)

ARID1A serves as a receivable biomarker for the resistance to EGFR-TKIs in non-small cell lung cancer
por: Sun, Dantong, et al.
Publicado: (2021)

Efficacy and safety of brigatinib in ALK-positive non-small cell lung cancer treatment: A systematic review and meta-analysis
por: Xing, Puyuan, et al.
Publicado: (2022)

Intracranial Meningiomas, WHO Grade Il : Prognostic Implications of Clinicopathologic Features
por: Moon, Hyung-Sik, et al.
Publicado: (2012)

Surgically Resected Esophageal Squamous Cell Carcinoma: Patient Survival and Clinicopathological Prognostic Factors
por: Jeong, Dong Young, et al.
Publicado: (2020)

Heterogeneity of resistant mechanisms in an EGFR-TKI relapsed patient with EGFR amplification and response to nimotuzumab: A case report
por: Li, Yan, et al.
Publicado: (2022)

Real-World Data Of Osimertinib In Patients With Pretreated Non-Small Cell Lung Cancer: A Retrospective Study
por: Mu, Yuxin, et al.
Publicado: (2019)

Whole exome sequencing (WES) analysis of transformed small cell lung cancer (SCLC) from lung adenocarcinoma (LUAD)
por: Xie, Tongji, et al.
Publicado: (2020)

Clinicopathological Features and Prognostic Factors of Young Patients With Surgically Treated Liver Cancer
por: Zhang, Wenjie, et al.
Publicado: (2015)

Expression Profiles and Clinicopathologic Features in Early Resected Non-small-cell Lung Cancer()
por: Rosell, Rafael
Publicado: (2014)

Exploration of the Tumor-Suppressive Immune Microenvironment by Integrated Analysis in EGFR-Mutant Lung Adenocarcinoma
por: Li, Teng, et al.
Publicado: (2021)

Disease monitoring of epidermal growth factor receptor (EGFR)‐mutated non‐small‐cell lung cancer patients treated with tyrosine kinase inhibitors via EGFR status in circulating tumor DNA
por: Li, Yan, et al.
Publicado: (2022)

Clinicopathologic features and prognostic value of claudin 18.2 overexpression in patients with resectable gastric cancer
por: Kim, Hyung-Don, et al.
Publicado: (2023)

Clinical effect of pemetrexed as the first‐line treatment in Chinese patients with advanced anaplastic lymphoma kinase‐positive non‐small cell lung cancer
por: Ma, Di, et al.
Publicado: (2016)

Clinical data from the real world: efficacy of Crizotinib in Chinese patients with advanced ALK-rearranged non-small cell lung cancer and brain metastases
por: Xing, Puyuan, et al.
Publicado: (2016)

Intestinal Stem Cell Marker ASCL2 is a Novel Prognostic Predictor in Esophageal Adenocarcinoma
por: Shibahara, Yukiko, et al.
Publicado: (2022)

Clinicopathological features, surgical treatments, and survival outcomes of patients with small bowel adenocarcinoma
por: Zhang, Shuisheng, et al.
Publicado: (2017)

Clinicopathological and prognostic features of surgically resected pathological stage I lung adenocarcinoma harboring epidermal growth factor receptor and K‐ras mutation
por: Kaseda, Kaoru, et al.
Publicado: (2017)

Clinicopathological features and post-resection outcomes of hepatocellular adenoma
por: Kim, Sung-Min, et al.
Publicado: (2021)

Long-term outcome after liver resection and clinicopathological features in patients with small hepatocellular carcinoma
por: Hong, Young Ju, et al.
Publicado: (2011)

Clinical features and outcomes of ALK rearranged non‐small cell lung cancer with primary resistance to crizotinib
por: Ma, Di, et al.
Publicado: (2019)

Comparison of Clinicopathological Features and Prognosis between ALK Rearrangements and EGFR Mutations in Surgically Resected Early-stage Lung Adenocarcinoma
por: Li, Pupu, et al.
Publicado: (2019)

The prognostic implications of Notch1, Hes1, Ascl1, and DLL3 protein expression in SCLC patients receiving platinum-based chemotherapy
por: Tendler, Salomon, et al.
Publicado: (2020)

MAPK pathway activation selectively inhibits ASCL1-driven small cell lung cancer
por: Caeser, Rebecca, et al.
Publicado: (2021)

Subcellular localisation modulates ubiquitylation and degradation of Ascl1
por: Gillotin, Sébastien, et al.
Publicado: (2018)

Valproic acid silencing of ascl1b/Ascl1 results in the failure of serotonergic differentiation in a zebrafish model of fetal valproate syndrome
por: Jacob, John, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_qclih32f2djga1aq4r0a5ukpvk